| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -660,706 | 100% | $32.38 | -$21,393,278 |
| Net | -8 | -660,706 | -100% | -$21,393,278 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Eric M. Dube | CHIEF EXECUTIVE OFFICER, Director | $13,028,180 | -$10,877,998 | -46% | 20 Feb 2026 |
| Peter Heerma | Chief Commercial Officer | $4,234,154 | -$746,822 | -15% | 31 Jan 2026 |
| Christopher R. Cline | Chief Financial Officer | $3,628,628 | -$1,045,911 | -22% | 04 Feb 2026 |
| WILLIAM E. ROTE | Chief Research Officer | $3,585,689 | -$2,882,598 | -45% | 31 Jan 2026 |
| Jula Inrig | Chief Medical Officer | $3,452,418 | -$1,021,071 | -23% | 04 Feb 2026 |
| Elizabeth E. Reed | Chief Legal Officer and GC | $2,973,473 | -$1,232,121 | -29% | 17 Feb 2026 |
| Timothy Coughlin | Director | $1,944,353 | -$630,601 | -24% | 31 Oct 2025 |
| Jeffrey A. Meckler | Director | $1,603,875 | 15 May 2025 | ||
| Sandra Calvin | Svp, Chief Accounting Officer | $1,576,449 | -$2,956,156 | -65% | 31 Jan 2026 |
| STEVE ASELAGE | Director | $1,316,394 | 11 May 2022 | ||
| GARY A. LYONS | Director | $1,053,975 | 15 May 2025 | ||
| Roy D. Baynes | Director | $687,375 | 15 May 2025 | ||
| John A. Orwin | Director | $648,423 | 15 May 2025 | ||
| Ron Squarer | Director | $648,423 | 15 May 2025 | ||
| Sandra Poole | Director | $549,900 | 15 May 2025 | ||
| Suzanne Louise Bruhn | Director | $526,987 | 15 May 2025 | ||
| Brinkley Ruth Williams | Director | $471,997 | 15 May 2025 | ||
| Noah L. Rosenberg | Chief Medical Officer | $426,621 | 13 Aug 2021 | ||
| Laura Clague | Chief Financial Officer | $319,469 | 10 May 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|